Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Archit Organosys Ltd. is underperforming compared to its peers, particularly in terms of revenue growth and profitability metrics. However, it exhibits a moderate debt-equity ratio which is favorable in the context of its financial health. Peers like Pidilite Industries and Solar Industries show robust growth and profitability, making them attractive investments, while companies like Godrej Industries appear overvalued and financially risky due to high debt and low margins.
Highest ROE (22.45%) and consistent revenue growth (6.12% YoY) make it a profitable investment.
Strong EPS growth and high ROE (29.59%) showcase its robust financial health.